DA Davidson Weighs in on Nutrisystem’s Q2 2018 Earnings (NTRI)

Nutrisystem (NASDAQ:NTRI) – Equities researchers at DA Davidson reduced their Q2 2018 EPS estimates for shares of Nutrisystem in a research report issued on Tuesday, Zacks Investment Research reports. DA Davidson analyst L. Weiser now expects that the company will post earnings of $0.93 per share for the quarter, down from their previous forecast of $0.94. DA Davidson currently has a “Buy” rating and a $80.00 target price on the stock. DA Davidson also issued estimates for Nutrisystem’s Q4 2018 earnings at $0.50 EPS, FY2018 earnings at $2.09 EPS and FY2019 earnings at $2.37 EPS.

Nutrisystem (NASDAQ:NTRI) last released its quarterly earnings data on Monday, February 26th. The company reported $0.42 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.02. Nutrisystem had a net margin of 8.30% and a return on equity of 48.69%. The firm had revenue of $131.20 million for the quarter, compared to analyst estimates of $128.75 million. During the same period last year, the firm earned $0.29 earnings per share. The business’s quarterly revenue was up 20.5% compared to the same quarter last year.

A number of other research firms have also weighed in on NTRI. Barrington Research lowered shares of Nutrisystem from an “outperform” rating to a “market perform” rating in a research note on Tuesday, February 27th. B. Riley set a $52.00 price objective on shares of Nutrisystem and gave the company a “buy” rating in a research note on Wednesday, February 28th. Zacks Investment Research lowered shares of Nutrisystem from a “buy” rating to a “hold” rating in a research note on Friday, December 15th. Craig Hallum dropped their price target on shares of Nutrisystem from $80.00 to $50.00 and set a “buy” rating on the stock in a research report on Tuesday, February 27th. Finally, BidaskClub lowered shares of Nutrisystem from a “hold” rating to a “sell” rating in a research report on Friday, February 23rd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and six have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $57.00.

Nutrisystem stock traded down $0.60 during trading on Thursday, hitting $27.40. 774,298 shares of the company’s stock were exchanged, compared to its average volume of 915,088. Nutrisystem has a 12-month low of $27.40 and a 12-month high of $67.95. The company has a market capitalization of $874.52, a price-to-earnings ratio of 14.42, a price-to-earnings-growth ratio of 0.85 and a beta of 1.03.

The company also recently declared a quarterly dividend, which was paid on Monday, March 19th. Investors of record on Thursday, March 8th were given a dividend of $0.25 per share. This is a positive change from Nutrisystem’s previous quarterly dividend of $0.18. This represents a $1.00 dividend on an annualized basis and a dividend yield of 3.65%. The ex-dividend date of this dividend was Wednesday, March 7th. Nutrisystem’s dividend payout ratio (DPR) is presently 52.63%.

In other Nutrisystem news, CEO Dawn M. Zier sold 30,006 shares of Nutrisystem stock in a transaction dated Friday, January 12th. The shares were sold at an average price of $52.36, for a total value of $1,571,114.16. Following the sale, the chief executive officer now owns 224,659 shares of the company’s stock, valued at $11,763,145.24. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Dawn M. Zier sold 30,825 shares of Nutrisystem stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $40.37, for a total transaction of $1,244,405.25. Following the completion of the sale, the insider now directly owns 221,013 shares in the company, valued at approximately $8,922,294.81. The disclosure for this sale can be found here. Insiders have sold 75,831 shares of company stock worth $3,566,319 over the last three months. 2.40% of the stock is owned by insiders.

A number of hedge funds have recently made changes to their positions in the business. BlackRock Inc. raised its position in Nutrisystem by 3.3% in the fourth quarter. BlackRock Inc. now owns 3,819,640 shares of the company’s stock worth $200,912,000 after acquiring an additional 121,738 shares during the period. Eagle Asset Management Inc. raised its position in Nutrisystem by 9.4% in the fourth quarter. Eagle Asset Management Inc. now owns 2,202,208 shares of the company’s stock worth $114,445,000 after acquiring an additional 189,317 shares during the period. Carillon Tower Advisers Inc. bought a new stake in Nutrisystem in the fourth quarter worth about $96,114,000. Dimensional Fund Advisors LP raised its position in Nutrisystem by 1.5% in the third quarter. Dimensional Fund Advisors LP now owns 1,122,395 shares of the company’s stock worth $62,741,000 after acquiring an additional 16,610 shares during the period. Finally, Thrivent Financial For Lutherans raised its position in Nutrisystem by 16.6% in the fourth quarter. Thrivent Financial For Lutherans now owns 901,040 shares of the company’s stock worth $47,394,000 after acquiring an additional 128,422 shares during the period.

TRADEMARK VIOLATION WARNING: This report was published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this report on another site, it was illegally stolen and republished in violation of US & international copyright & trademark law. The correct version of this report can be viewed at https://ledgergazette.com/2018/03/23/da-davidson-weighs-in-on-nutrisystems-q2-2018-earnings-ntri.html.

Nutrisystem Company Profile

Nutrisystem, Inc, together with its subsidiaries, provides weight management products and services for women and men in the United States. The company offers weight loss programs that consist primarily of a pre-packaged food program, digital tools, and counseling. It also provides Nutrisystem Lean13 program, which provides weight loss, and support and counseling services; the South Beach Diet, a weight-loss program; and Nutrisystem 5-day kit, a ?D' kit that offers individuals with or at risk of type 2 diabetes.

Get a free copy of the Zacks research report on Nutrisystem (NTRI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Nutrisystem (NASDAQ:NTRI)

Leave a Reply